Literature DB >> 7675176

The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization.

W J Sheward1, E M Lutz, A J Harmar.   

Abstract

The distribution of rat vasoactive intestinal peptide2 (VIP2) receptor messenger RNA in the brain and the pituitary gland was examined by in situ hybridization and by ribonuclease protection assay. labelled cells were found chiefly in the suprachiasmatic nucleus, the central nucleus of the amygdala and the thalamus (the lateral geniculate nucleus, and the paraventricular, mediodorsal and ventral nuclei of the thalamus). The distribution of the VIP2 receptor overlaps only in part with that of the VIP1 receptor, for example in the hippocampus, where VIP2 receptor messenger RNA was found in the pyramidal cells of the CA1-CA3 subfields and in the granule cells of the dentate gyrus. Small numbers of neurons containing high concentrations of VIP2 receptor messenger RNA were present in the brainstem in the principal sensory trigeminal nucleus and in the substantia gelatinosa of the spinal cord, suggesting a role for the VIP2 receptor in the processing of sensory information. The presence of the VIP2 receptor in the suprachiasmatic nucleus suggests that it is this receptor subtype which is involved in the control of circadian rhythms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675176     DOI: 10.1016/0306-4522(95)00048-n

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  30 in total

1.  IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.

Authors:  Tomoya Nakamachi; Masashi Tsuchida; Nobuyuki Kagami; Sachiko Yofu; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Akira Yoshikawa; Nori Imai; Keisuke Nakamura; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-06       Impact factor: 3.444

2.  Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice.

Authors:  S Shen; C Spratt; W J Sheward; I Kallo; K West; C F Morrison; C W Coen; H M Marston; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 3.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Excitatory actions of peptide histidine isoleucine on thalamic relay neurons.

Authors:  Sang-Hun Lee; Charles L Cox
Journal:  Neuropharmacology       Date:  2008-08-30       Impact factor: 5.250

5.  Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model.

Authors:  Xinli Tian; Adam Richard; Madison Wynne El-Saadi; Aakriti Bhandari; Brian Latimer; Isabella Van Savage; Kevlyn Holmes; Ronald L Klein; Donard Dwyer; Nicholas E Goeders; X William Yang; Xiao-Hong Lu
Journal:  Mol Psychiatry       Date:  2019-08-23       Impact factor: 15.992

6.  Oxytocin participates on the effects of vasoactive intestinal peptide on food intake and plasma parameters.

Authors:  Andressa B Martins; Marcela C Garnica-Siqueira; Dimas A M Zaia; Cássia Thaïs B V Zaia; Ernane T Uchôa
Journal:  Mol Cell Biochem       Date:  2017-07-27       Impact factor: 3.396

7.  Impaired extinction of cued fear memory and abnormal dendritic morphology in the prelimbic and infralimbic cortices in VPAC2 receptor (VIPR2)-deficient mice.

Authors:  Yukio Ago; Atsuko Hayata-Takano; Takuya Kawanai; Ryosuke Yamauchi; Shuto Takeuchi; Jesse D Cushman; Abha K Rajbhandari; Michael S Fanselow; Hitoshi Hashimoto; James A Waschek
Journal:  Neurobiol Learn Mem       Date:  2017-10-10       Impact factor: 2.877

8.  Adrenalectomy impairs vasoactive intestinal peptide-induced changes in food intake and plasma parameters.

Authors:  Marcela Cristina Garnica-Siqueira; Andressa Bussetti Martins; Larissa Rugila Dos Stopa; Camila Franciele de Souza; Dimas Augusto Morozin Zaia; Cristiane Mota Leite; Cássia Thaïs Bussamra Vieira Zaia; Ernane Torres Uchôa
Journal:  Endocrine       Date:  2019-07-19       Impact factor: 3.633

Review 9.  Vasoactive intestinal peptide and the mammalian circadian system.

Authors:  Andrew M Vosko; Analyne Schroeder; Dawn H Loh; Christopher S Colwell
Journal:  Gen Comp Endocrinol       Date:  2007-05-26       Impact factor: 2.822

10.  Central clock regulates the cervically stimulated prolactin surges by modulation of dopamine and vasoactive intestinal polypeptide release in ovariectomized rats.

Authors:  Maristela O Poletini; Jessica E Kennett; De'nise T McKee; Marc E Freeman
Journal:  Neuroendocrinology       Date:  2009-10-29       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.